Sutro Biopharma, Inc. (NASDAQ:STRO - Free Report) - Investment analysts at HC Wainwright increased their Q4 2026 earnings estimates for shares of Sutro Biopharma in a note issued to investors on Friday, November 13th. HC Wainwright analyst A. Maldonado now forecasts that the company will post earnin